294 related articles for article (PubMed ID: 27061427)
1. Prevalence, characteristics, and treatment outcomes of reflux hypersensitivity detected on pH-impedance monitoring.
Patel A; Sayuk GS; Gyawali CP
Neurogastroenterol Motil; 2016 Sep; 28(9):1382-90. PubMed ID: 27061427
[TBL] [Abstract][Full Text] [Related]
2. GERD phenotypes from pH-impedance monitoring predict symptomatic outcomes on prospective evaluation.
Patel A; Sayuk GS; Kushnir VM; Chan WW; Gyawali CP
Neurogastroenterol Motil; 2016 Apr; 28(4):513-21. PubMed ID: 26686239
[TBL] [Abstract][Full Text] [Related]
3. Parameters on esophageal pH-impedance monitoring that predict outcomes of patients with gastroesophageal reflux disease.
Patel A; Sayuk GS; Gyawali CP
Clin Gastroenterol Hepatol; 2015 May; 13(5):884-91. PubMed ID: 25158924
[TBL] [Abstract][Full Text] [Related]
4. Acid-based parameters on pH-impedance testing predict symptom improvement with medical management better than impedance parameters.
Patel A; Sayuk GS; Gyawali CP
Am J Gastroenterol; 2014 Jun; 109(6):836-44. PubMed ID: 24732868
[TBL] [Abstract][Full Text] [Related]
5. Mean Nocturnal Baseline Impedance Correlates With Symptom Outcome When Acid Exposure Time Is Inconclusive on Esophageal Reflux Monitoring.
Rengarajan A; Savarino E; Della Coletta M; Ghisa M; Patel A; Gyawali CP
Clin Gastroenterol Hepatol; 2020 Mar; 18(3):589-595. PubMed ID: 31163276
[TBL] [Abstract][Full Text] [Related]
6. Abnormal GERD parameters on ambulatory pH monitoring predict therapeutic success in noncardiac chest pain.
Kushnir VM; Sayuk GS; Gyawali CP
Am J Gastroenterol; 2010 May; 105(5):1032-8. PubMed ID: 19920808
[TBL] [Abstract][Full Text] [Related]
7. Proton pump inhibitor responders who are not confirmed as GERD patients with impedance and pH monitoring: who are they?
de Bortoli N; Martinucci I; Savarino E; Bellini M; Bredenoord AJ; Franchi R; Bertani L; Furnari M; Savarino V; Blandizzi C; Marchi S
Neurogastroenterol Motil; 2014 Jan; 26(1):28-35. PubMed ID: 23992024
[TBL] [Abstract][Full Text] [Related]
8. Distal mean nocturnal baseline impedance on pH-impedance monitoring predicts reflux burden and symptomatic outcome in gastro-oesophageal reflux disease.
Patel A; Wang D; Sainani N; Sayuk GS; Gyawali CP
Aliment Pharmacol Ther; 2016 Oct; 44(8):890-8. PubMed ID: 27554638
[TBL] [Abstract][Full Text] [Related]
9. 24-hour pH-impedance monitoring on therapy to select patients with refractory reflux symptoms for antireflux surgery. A single center retrospective study.
Desjardin M; Luc G; Collet D; Zerbib F
Neurogastroenterol Motil; 2016 Jan; 28(1):146-52. PubMed ID: 26526815
[TBL] [Abstract][Full Text] [Related]
10. Endoscopic measurement of gastric pH associates with persistent acid reflux in patients treated with proton-pump inhibitors for gastroesophageal reflux disease.
Januszewicz W; Hartley J; Waldock W; Roberts G; Alias B; Hobson A; Wernisch L; di Pietro M
United European Gastroenterol J; 2019 Dec; 7(10):1389-1398. PubMed ID: 31807307
[TBL] [Abstract][Full Text] [Related]
11. Psychosocial Distress and Quality of Life Impairment Are Associated With Symptom Severity in PPI Non-Responders With Normal Impedance-pH Profiles.
Yadlapati R; Tye M; Keefer L; Kahrilas PJ; Pandolfino JE
Am J Gastroenterol; 2018 Jan; 113(1):31-38. PubMed ID: 28895583
[TBL] [Abstract][Full Text] [Related]
12. Higher obesity class is associated with more severe esophageal symptoms and reflux burden but not altered motor function or contractile reserve.
Hiramoto B; Redd WD; Muftah M; Jonnadula S; Okwara NC; Jenkins A; Cricco-Lizza E; Lee DJH; Cai JX; Chan WW
Neurogastroenterol Motil; 2024 Jan; 36(1):e14691. PubMed ID: 37849439
[TBL] [Abstract][Full Text] [Related]
13. Esophageal pH-impedance monitoring in patients with therapy-resistant reflux symptoms: 'on' or 'off' proton pump inhibitor?
Hemmink GJ; Bredenoord AJ; Weusten BL; Monkelbaan JF; Timmer R; Smout AJ
Am J Gastroenterol; 2008 Oct; 103(10):2446-53. PubMed ID: 18684197
[TBL] [Abstract][Full Text] [Related]
14. Majority of symptoms in esophageal reflux PPI non-responders are not related to reflux.
Roman S; Keefer L; Imam H; Korrapati P; Mogni B; Eident K; Friesen L; Kahrilas PJ; Martinovich Z; Pandolfino JE
Neurogastroenterol Motil; 2015 Nov; 27(11):1667-74. PubMed ID: 26337396
[TBL] [Abstract][Full Text] [Related]
15. Artificial intelligence automates and augments baseline impedance measurements from pH-impedance studies in gastroesophageal reflux disease.
Rogers B; Samanta S; Ghobadi K; Patel A; Savarino E; Roman S; Sifrim D; Gyawali CP
J Gastroenterol; 2021 Jan; 56(1):34-41. PubMed ID: 33151406
[TBL] [Abstract][Full Text] [Related]
16. How many cases of laryngopharyngeal reflux suspected by laryngoscopy are gastroesophageal reflux disease-related?
de Bortoli N; Nacci A; Savarino E; Martinucci I; Bellini M; Fattori B; Ceccarelli L; Costa F; Mumolo MG; Ricchiuti A; Savarino V; Berrettini S; Marchi S
World J Gastroenterol; 2012 Aug; 18(32):4363-70. PubMed ID: 22969200
[TBL] [Abstract][Full Text] [Related]
17. Overlap of functional heartburn and reflux hypersensitivity with proven gastroesophageal reflux disease.
Rengarajan A; Pomarat M; Zerbib F; Gyawali CP
Neurogastroenterol Motil; 2021 Jun; 33(6):e14056. PubMed ID: 33300667
[TBL] [Abstract][Full Text] [Related]
18. The effect of antisecretory therapy and study duration on ambulatory esophageal pH monitoring.
Kushnir VM; Sayuk GS; Gyawali CP
Dig Dis Sci; 2011 May; 56(5):1412-9. PubMed ID: 21046245
[TBL] [Abstract][Full Text] [Related]
19. Value of pH Impedance Monitoring While on Twice-Daily Proton Pump Inhibitor Therapy to Identify Need for Escalation of Reflux Management.
Gyawali CP; Tutuian R; Zerbib F; Rogers BD; Frazzoni M; Roman S; Savarino E; de Bortoli N; Vela MF; Sifrim D
Gastroenterology; 2021 Nov; 161(5):1412-1422. PubMed ID: 34270955
[TBL] [Abstract][Full Text] [Related]
20. Number of reflux episodes on pH-impedance monitoring associates with improved symptom outcome and treatment satisfaction in gastro-oesophageal reflux disease (GERD) patients with regurgitation.
Rogers BD; Valdovinos LR; Crowell MD; Bell R; Vela MF; Gyawali CP
Gut; 2021 Mar; 70(3):450-455. PubMed ID: 32467089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
